Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

David Arciniegas to Attention

This is a "connection" page, showing publications David Arciniegas has written about Attention.

 
Connection Strength
 
 
 
0.552
 
  1. Arciniegas D, Olincy A, Topkoff J, McRae K, Cawthra E, Filley CM, Reite M, Adler LE. Impaired auditory gating and P50 nonsuppression following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2000; 12(1):77-85.
    View in: PubMed
    Score: 0.138
  2. Simonetti A, Lijffijt M, Kahlon RS, Gandy K, Arvind RP, Amin P, Arciniegas DB, Swann AC, Soares JC, Saxena K. Early and late cortical reactivity to passively viewed emotional faces in pediatric bipolar disorder. J Affect Disord. 2019 06 15; 253:240-247.
    View in: PubMed
    Score: 0.131
  3. Arciniegas D, Adler L, Topkoff J, Cawthra E, Filley CM, Reite M. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj. 1999 Jan; 13(1):1-13.
    View in: PubMed
    Score: 0.128
  4. Arciniegas DB, Topkoff JL. Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury. Phys Med Rehabil Clin N Am. 2004 Feb; 15(1):177-203, viii.
    View in: PubMed
    Score: 0.046
  5. Arciniegas D, Rojas DC, Teale P, Sheeder J, Sandberg E, Reite M. The thalamus and the schizophrenia phenotype: failure to replicate reduced volume. Biol Psychiatry. 1999 May 15; 45(10):1329-35.
    View in: PubMed
    Score: 0.033
  6. McDonald BC, Flashman LA, Arciniegas DB, Ferguson RJ, Xing L, Harezlak J, Sprehn GC, Hammond FM, Maerlender AC, Kruck CL, Gillock KL, Frey K, Wall RN, Saykin AJ, McAllister TW. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial. Neuropsychopharmacology. 2017 Aug; 42(9):1766-1775.
    View in: PubMed
    Score: 0.028
  7. Kozora E, Filley CM, Zhang L, Brown MS, Miller DE, Arciniegas DB, Pelzman JL, West SG. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations. Lupus. 2012 Apr; 21(4):402-11.
    View in: PubMed
    Score: 0.020
  8. Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, Grimm A, Devore MD, Wingrove C, Zhang L. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum. 2008 Nov 15; 59(11):1639-46.
    View in: PubMed
    Score: 0.016
  9. Kozora E, Arciniegas DB, Filley CM, Ellison MC, West SG, Brown MS, Simon JH. Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol. 2005 Sep; 18(3):159-62.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)